Clinical Trial Update: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated whether adding tocilizumab to methotrexate could prevent structural joint damage in adults with moderate-to-severe rheumatoid arthriti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Actemra (tocilizumab)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2011-06-07